JAMIE POLK: Open Payments
NPI 1174159800 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,237 in 94 payments from 17 companies in 2025. Trend: 2023 $1,344 · 2024 $1,954 · 2025 $2,237
Food & beverage: $2,203Education: $34
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $429 |
| AstraZeneca Pharmaceuticals LP | 16 | $338 |
| Novartis Pharmaceuticals Corporation | 13 | $294 |
| GlaxoSmithKline, LLC. | 13 | $272 |
| Regeneron Healthcare Solutions, Inc. | 9 | $249 |
| BioCryst US Sales Co., LLC | 8 | $187 |
| Genentech USA, Inc. | 3 | $93 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $76 |
| Amgen Inc. | 2 | $60 |
| CSL Behring | 2 | $58 |
Products named: DUPIXENT, Xolair, NUCALA, FASENRA, ORLADEYO, Rhapsido, AIRSUPRA, NEFFY.
Industry payments across GA — which companies pay providers there.
